- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹558.3b
Operates as a pharmaceutical company in India.
500488
₹26,272.05
7D
1.0%
1Y
-16.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹359.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,120.70
7D
-2.1%
1Y
-35.7%
Sanofi India
Market Cap: ₹71.9b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,119.95
7D
-2.0%
1Y
-49.3%